Winnipeg Chapter of the Society for Neuroscience

Brain Awareness Week 2001 Activities
March 12-18, 2001

Brain Awareness Days - Thursday, March 15th & Friday, March 16th, 2001
University of Manitoba, St. Boniface Research Centre

Brain Awareness Week 2001 is an international event and is coordinated locally by the Winnipeg Chapter of the Society for Neuroscience. The Society for Neurosciences' National Brain Awareness Week (BAW) is scheduled for March 12th-18th, 2001.

The Winnipeg Chapter Society for Neuroscience invites you to attend the "Brain Awareness Day" to be held March 15 & 16, 2001. This event is hosted by the Winnipeg Chapter Society for Neuroscience. There are four presentations scheduled over the two days. On March 16, there will be displays by local not-for-profit organizations, foundations, etc. Below are notices of all of the events, in PDF format, so that you can print off and circulate within your department. Also included, is an itinerary for those attending the meetings.

If you are interested in participating in the meetings, and have not been contacted, please call Dr. Jonathan Geiger at (204) 235-3938 or email him at geiger@cc.umanitoba.ca. We would like to encourage everyone's participation in this very important event.

See the Complete Programme (58k PDF) for BAW 2001, and the Itineraries (8k PDF) for our guest speakers.

Keynote speakers for March 2001

Day 1: March 15, Bannatyne Campus

Presentation #1: March 15, 1-2 pm.
Dr. Rémi Quirion,
CIHR Scientific Director,
Institutes of Neuroscience & Mental Health & Addictions
Thursday, March 15/01, 1:00 - 2:00 p.m.
Theatre "A", Basic Med. Sciences Bldg.
730 William Ave.

"The Canadian Institute for Neurosciences, Mental health and Addictions: Challenges and opportunities"

See the Poster (43k PDF) for this talk.

Day 2: March 16, St. Boniface Research Centre

Brain Awareness Day - Opening remarks and introductions
Friday, March 16/01, 9:30 a.m.
Atrium, St. Boniface Research Centre
Dr. Jonathan Geiger, Director, DNND
Dr. John Foerster, Director (Research), SBRC
Dr. Joanne Keselman, VP (Research), UM
Dr. Larry Jordan, Director, Spinal Cord Research Centre, UM

Overview of Neuroscience Research in Manitoba
Friday, March 16/01, 9:50 a.m.
Atrium, St. Boniface Research Centre
Presentation by Dr. Larry Jordan

Presentation #2: March 16, 10:00-10:45 am.
Dr. David Westaway,
Associate Professor,
University of Toronto, Centre for Research in Neurodegenerative Diseases
Friday, March 16/01, 10:00 a.m. - 10:45 a.m.
Samuel Cohen Auditorium, St. Boniface Hospital Research Centre
351 Tache Ave.

"PrP and Doppel: Double prion trouble"

See the Poster (66k PDF) for this talk.

Presentation #3: March 16, 11 am-12:15 pm.
Dr. Rémi Quirion,
CIHR Scientific Director,
Institutes of Neuroscience & Mental Health & Addictions
Friday, March 16/01, 11:00 a.m. - 12:15 p.m.
Samuel Cohen Auditorium, St. Boniface Hospital Research Centre
351 Tache Ave.

"Interactions between key phenotypes of the Alzheimer's brain: possible significance for treatment"

See the Poster (43k PDF) for this talk.

Neuroscience & Mental Health Displays
Friday, March 16/01, 11:30 a.m. - 4:00 p.m.
Atrium, St. Boniface Research Centre

Break & Refreshments
Friday, March 16/01, 12:15 p.m. - 1:00 p.m.
Atrium, St. Boniface Research Centre

Presentation #4: March 16, 1-2:15 pm.
Dr. David Westaway,
Associate Professor,
University of Toronto, Centre for Research in Neurodegenerative Diseases
Friday, March 16/01, 1:00 p.m. - 2:15 p.m.
Samuel Cohen Auditorium, St. Boniface Hospital Research Centre
351 Tache Ave.

"Alzheimer's disease: Models and mechanisms"

See the Poster (43k PDF) for this talk.

About our Keynote Speakers

Dr. Rémi Quirion is a Full Professor and Scientific Director at the Douglas Hospital Research Centre (a McGill affiliated teaching hospital) in Montreal and the Head of the provincial network on mental health supported by the Fonds de la recherche en santé du Québec (FRSQ). Under his leadership, the Douglas Hospital Research Centre became a premier research facility in Canada in the fields of neurosciences and mental health. Dr. Quirion promoted the development of clinical research in Neurology and Psychiatry as well as social and evaluation aspects of research in mental health and addiction. A member of the FRSQ Board of Directors, Dr. Quirion is also active on many other national bodies. His research interests include: understanding the relationships between key phenotypes of the Alzheimer's brain, molecular and pharmacological features of neuropeptide receptors focussing on NPY and CGRP, and their role in memory, pain and drug dependence, and models of schizophrenia. A major interest lies in the training of the next generation of scientists. In addition to being on the Advisory Board of over 15 scientific journals in Psychiatry, Pharmacology, and Neurosciences, Dr. Quirion has published 5 books and more than 500 scientific papers and articles.

See the bio for Dr. Quirion (5k PDF).

Dr. David Westaway is a molecular biologist with a special interest in the use of genetically-engineered "transgenic" mice to recreate and decipher human neurologic disorders. He obtained a first class degree in Biochemistry from the University of Sussex, England. He than went on to complete his PhD at St Mary's Hospital Medical School, University of London, under the guidance of Prof. Bob Williamson FRS. This work revealed that a form of thalassaemia minor was due to an RNA splicing defect in the b-globin gene.

Dr. Westaway completed postdoctoral training with two Nobel Laureates, Harold Varmus and Stanley Prusiner, both at the University of California San Francisco. With Prof. Varmus, David worked on the weakly oncogenic avian retroviruses and identified insertional mutations in the c-myc and Ha-ras protoncogenes. With Prof. Prusiner David participated in many ground breaking studies of the molecular biology of the prion disease, including the characterization of disease modulating polymorphisms in the prion protein structural gene.

Dr. Westaway is appointed as an Associate Professor at the Centre for Research in Neurodegenerative Diseases (CRND) at the University of Toronto. His recent work on prions includes defining a cooperative copper binding site in the prion protein and the discovery of the Doppel gene, a PrP like protein that resolves a long-standing paradox concerning prion protein gene ablated mice. David's work on the structure and function of the Doppel protein is funded by the CIHR. Other work on prions examines the effects of prion protein deamidation and the development of a novel retinal expression system for prion proteins, and is supported by the Bayer/Canadian Blood Services/Hema Quebec Research Partnership Fund. Dr Westaway is also involved in studies of Alzheimer Disease with Drs. Peter St George-Hyslop and Paul Fraser of the CRND. Objectives here are to create transgenic models, test therapies, and to examine the genetics of gamma-secretase activity.

See the bio for Dr. Westaway (5k PDF).

Our Sponsors

Manitoba Heart & Stroke Foundation
Manitoba Brain Injury Association
Epilepsy Manitoba
Dept. of Pharmacology & Therapeutics, University of Manitoba
National Research Council of Canada
AstraZeneca Pharmaceutical Inc.
St. Boniface Hospital Research Centre

Brain Awareness Week activities in Manitoba are part of WCSN's participation in the Society For Neuroscience's Brain Awareness Week 2001. Check out the international Brain Awareness Week web site.

Please see the highlights of last year's event as well as our photos.

April 26, 2001 Update: Brain Awareness Week 2001 Photos 46k PDF.

[Get Acrobat Reader] PDF files are readable with Adobe Acrobat.


WCSN webmaster: www (at) sfn-manitoba.ca
This page was prepared by Kelly Jorundson and Gilles Detillieux, November 30, 2000. Revised March 13, 2001.